Full-Time

Corporate Paralegal

Posted on 7/4/2025

Sotera Health

Sotera Health

1,001-5,000 employees

Outsourced sterilization and lab testing provider.

No salary listed

Seven Hills, OH, USA

Hybrid

Hybrid role; based in Broadview Heights, OH. #LI-HYBRID; expected some in-office days.

Category
Legal & Compliance (1)
Required Skills
Risk Management
Requirements
  • Associate’s degree in paralegal studies, paralegal certification approved by the American Bar Association, or comparable experience
  • A minimum of 5 years of relevant experience as a paralegal in a private law firm or corporate legal department to include international experience
  • Broad knowledge of the principles of judicial and administrative process, knowledge of research procedures, publications and periodicals
  • Broad knowledge of the basic principles of state and foreign laws regarding legal entities and knowledge of corporate record keeping with respect thereto
  • Experience with SEC filings and public company governance preferred
  • Experience reviewing, approving, and processing vendor and counsel invoices and other expenses
  • Superlative organizational, analytic, verbal and writing skills
  • Superior interpersonal skills; ability to work with others at all levels of the organization and in all locations
  • Good business judgement and awareness of and compliance with legal privilege and confidentiality requirements; ability to complete tasks under pressure and/or strict deadlines; detail oriented; proactive and self-starter
  • Exhibits commitment to Sotera Health Company Values by focusing on safety, customer needs, people, integrity and excellence
Responsibilities
  • Responsible for corporate governance matters for domestic and international subsidiaries including (i) drafting minutes/actions of managers and governing bodies; (ii) creating and maintaining corporate records, including minute books; (iii) preparing, processing and maintaining legal entity filings, including annual filings and foreign qualifications; and (iv) maintain legal entity software to be the point of reference for entity information
  • Assist with preparation of selected public disclosures, such as materials for proxy statement
  • Create and maintain file management system for Legal Department for significant transactions, significant contracts and corporate governance matters
  • Assist in administration of outside counsel relationships; work with legal billing software to review billings/fees to project/engagement; support accounting function in periodic accruals of legal expenses in the company’s financial statements and related internal controls
  • Work with compliance software and services to conduct background due diligence on third parties with which the company and its subsidiaries interact, including for antibribery and export law compliance
  • Support insurance matters, including collaboration and support of risk management group and insurance brokers
  • Assist with the preparation of board and committee meetings, compliance and reporting
  • Liaise with outside counsel and internal stakeholders on intellectual property registration and maintenance
  • Support credit agreement compliance processes, including perfection certificate
  • Assist with debt and equity financings, intercompany financing, and other significant corporate transactions
  • Professionally handle legal and other matters involving confidential, proprietary and legally privileged documents and information
  • Support Legal Department and various business functions with various complex and sensitive matters and special projects as needed
Desired Qualifications
  • Experience with international experience
  • Experience with SEC filings and public company governance preferred
  • Experience reviewing, approving, and processing vendor and counsel invoices and other expenses

Sotera Health provides sterilization and lab testing services to ensure the safety of medical devices, pharmaceuticals, and food products. The company operates through three divisions: Sterigenics, which uses methods like Gamma and X-ray to eliminate contaminants; Nordion, which supplies the Cobalt-60 isotopes needed for irradiation; and Nelson Labs, which performs over 800 microbiological and analytical tests. Unlike many competitors, it offers a fully integrated supply chain by producing its own sterilization sources while maintaining a global network of 63 facilities and labs. Its goal is to protect global health by providing the mission-critical services required to bring safe healthcare products to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Broadview Heights, Ohio

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Sterigenics volumes grew 8% in 2025, driving mid-to-high single-digit growth.
  • Q1 2026 operating margin hit 28.2%, up from 22.4%, via pricing power.
  • Sessa Capital bought $175.8M stake in February 2026, signaling investor confidence.

What critics are saying

  • EPA EtO enforcement and California bans constrain Sterigenics capacity by 2027.
  • Q1 2026 free cash flow plunged to negative $16.73M from $35.6M prior year.
  • Nelson Labs underperforms with low-single-digit growth versus Sterigenics' 8% volumes.

What makes Sotera Health unique

  • Sotera Health integrates Sterigenics, Nordion, and Nelson Labs for end-to-end sterilization and testing.
  • Nordion supplies Cobalt-60 with 70-year reliability for gamma irradiation worldwide.
  • Nelson Labs performs over 900 microbiological and analytical tests across 15 global labs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Education Assistance

Employee Assistance Program (EAP)

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Globe and Mail
Mar 24th, 2026
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop

Detailed price information for Capital One Financial Corp (COF-N) from The Globe and Mail including charting and trades.

Intellectia.AI
Mar 23rd, 2026
Sessa Capital buys $175.8M stake in Sotera Health as shares outperform S&P 500

Sessa Capital has acquired an additional 10,630,381 shares of Sotera Health for approximately $175.80 million on 17 February 2026, bringing its quarter-end position value to $206.47 million. The transaction signals strong confidence in the healthcare services company. Sotera Health shares traded at $13.99 on Monday, representing an 18% gain over the past year, slightly outperforming the S&P 500's 15% increase. The company has generated revenue of approximately $1.16 billion and adjusted EBITDA near $600 million. Despite facing litigation and regulatory risks, Sotera Health's sustained growth potential continues attracting long-term investor interest. The substantial investment by Sessa Capital reinforces the company's position within the asset manager's portfolio.

Yahoo Finance
Mar 23rd, 2026
Sessa Capital invests $175M in Sotera Health following 21% stock drop

Sessa Capital purchased 10.63 million shares of Sotera Health in the fourth quarter for an estimated $175.80 million, according to a Securities and Exchange Commission filing dated 17 February. The stake now represents nearly 7% of Sessa Capital's reportable assets under management. Sotera Health provides sterilisation services and laboratory testing for medical device and pharmaceutical industries. The company generated $1.2 billion in revenue and $77.9 million in net income over the trailing twelve months. Despite 20 years of steady growth and adjusted EBITDA approaching $600 million, the stock has declined as investors focus on litigation risks, high leverage and regulatory concerns. The shares currently trade at $13.99, up 18% over the past year, with a market capitalisation of $4.0 billion.

Yahoo Finance
Mar 22nd, 2026
Sotera Health CFO reaffirms 5%–6.5% organic growth for 2026, eyes $500M–$600M free cash flow

Sotera Health's CFO Jon Lyons reaffirmed constant-currency organic growth guidance of 5% to 6.5% for 2026 at the KeyBanc Healthcare Forum. Sterigenics is expected to deliver mid- to high-single-digit growth, whilst Nordion and Nelson Labs will see lower-single-digit growth. The company closed 2025 with 5.2% organic revenue growth, maintaining over 50% EBITDA margins with a 118-basis-point improvement. Weaker Nelson Labs results were offset by stronger Sterigenics volumes of approximately 8%. Management prioritises free cash flow and capital discipline, targeting $500 million to $600 million over three years. Capital expenditure is expected to drop significantly in 2027 as projects complete. Net leverage has improved towards the 2x–3x target, providing flexibility for debt reduction, acquisitions or share buybacks.

Yahoo Finance
Mar 2nd, 2026
Sotera Health up 30% in a year as fund trims $3.6M stake but maintains conviction

Ananym Capital Management sold 217,684 shares of Sotera Health for an estimated $3.60 million in February 2026, according to an SEC filing. Despite the sale, Sotera Health remains a significant holding at 8.65% of Ananym's assets under management. Sotera Health shares were trading at $17.09 as of 17 February 2026, up nearly 30% over the past year and outperforming the S&P 500 by 14.86 percentage points. The company provides sterilisation services and laboratory testing for medical device, pharmaceutical and food industries. Sotera recently reported its 20th consecutive year of revenue growth, with 2025 revenues rising nearly 6% to $1.16 billion. Management has guided for another 5% to 6.5% revenue increase in 2026, with adjusted EBITDA growth of 5.5% to 7%.

INACTIVE